Your search history is turned on.
Date: November 28, 2018 Jurisdictions: Alberta
51-105F1_[F_Proposed].DOC Form 51-105F1 Notice OTC Issuer Ceases to be an OTC Reporting Issuer This is the form required under paragraph 4(1)(d) of Multilateral Instrument 51-105 Issuers Quoted in the U.S. Over-the-Counter Markets for an OTC issuer to give notice that it has ceased to be an OTC reporting issuer under section 3 of the Instrument...
11/27/2018 https://www.sec.gov/Archives/edgar/data/1533743/000149315218015821/ex32.htm https://www.sec.gov/Archives/edgar/data/1533743/000149315218015821/ex32.htm 1/2 EX-32.1 4 ex32.htm Exhibit 32.1 Written Statement of the Chief Executive and Financial Officer Pursuant to 18 U.S.C. 1350 Solely for the purposes of complying with 18 U.S.C. 1350, I, the undersigned C...
11/27/2018 https://www.sec.gov/Archives/edgar/data/1533743/000149315218015821/ex31-2.htm https://www.sec.gov/Archives/edgar/data/1533743/000149315218015821/ex31-2.htm 1/2 EX-31.2 3 ex31-2.htm Exhibit 31.2 CERTIFICATIONS I, James Stanker, Chief Financial Officer of PROCESSA PHARMACEUTICALS, INC. certify that: 1. I have reviewed this quarterly report on Form 10-Q ...
11/27/2018 https://www.sec.gov/Archives/edgar/data/1533743/000149315218015821/ex31-1.htm https://www.sec.gov/Archives/edgar/data/1533743/000149315218015821/ex31-1.htm 1/2 EX-31.1 2 ex31-1.htm Exhibit 31.1 CERTIFICATIONS I, David Young, Chief Executive Officer of PROCESSA PHARMACEUTICALS, INC. certify that: 1. I have reviewed this quarterly report on Form 10-Q of...
11/27/2018 https://www.sec.gov/Archives/edgar/data/1533743/000149315218015821/form10-q.htm https://www.sec.gov/Archives/edgar/data/1533743/000149315218015821/form10-q.htm 1/45 10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SE...
11/27/2018 https://www.sec.gov/Archives/edgar/data/1533743/000149315218014019/form8-k.htm https://www.sec.gov/Archives/edgar/data/1533743/000149315218014019/form8-k.htm 1/4 8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O...
11/27/2018 https://www.sec.gov/Archives/edgar/data/1533743/000149315218014019/ex99-1.htm https://www.sec.gov/Archives/edgar/data/1533743/000149315218014019/ex99-1.htm 1/3 EX-99.1 2 ex99-1.htm FOR IMMEDIATE RELEASE For More Information: Patrick Lin [email protected] 925-683-3218 PROCESSA PHARMACEUTICALS RECEIVES FDA CLEARANCE OF IND TO BEGIN PHASE 2 CLINICAL D...
11/27/2018 https://www.sec.gov/Archives/edgar/data/1533743/000149315218013033/form8-k.htm https://www.sec.gov/Archives/edgar/data/1533743/000149315218013033/form8-k.htm 1/4 8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O...
Date: September 6, 2018 Jurisdictions: Alberta
Form 51-l0SFl Notice - OTC Issuer Ceases to be an OTC Reporting Issuer This is the form required under paragraph 4(1)(d) of Multilateral Instrument 51-105 Issuers Quoted in the U.S. Over-the-Counter Markets for an OTC issuer to give notice that it has ceased to be an OTC reporting issuer under section 3 of the Instrument in a jurisdiction other than Quebec. In Quebec, a...
L1098139.PDF ITEM 1 - REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. (YYYY-MM-DD) ITEM 2 - PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whether an issuer is an investment fund, refer to section 1.1 of National Instrument 81-106 Investm...